{
    "title": "Cancer drug ruling 'disappointing'",
    "url": "https://www.dailymail.co.uk/wires/pa/article-2778952/Cancer-drug-ruling-disappointing.html",
    "date": "2014-10-03",
    "keywords": [
        "drug",
        "leukaemia",
        "treatment",
        "cancer",
        "obinutuzumab",
        "chemotherapy",
        "nice",
        "research",
        "use",
        "october",
        "health",
        "care",
        "guidance",
        "charity",
        "lymphoma",
        "condition",
        "companys",
        "submission",
        "press",
        "association",
        "gmt",
        "email",
        "hope",
        "institute",
        "excellence",
        "draft",
        "authority",
        "manufacturer",
        "ruling",
        "year",
        "gazyvaro",
        "antibody",
        "medication",
        "bodys",
        "immune",
        "system",
        "blood",
        "saidin",
        "risk",
        "worsening",
        "death",
        "company",
        "treatmentbut",
        "moneysir",
        "chief",
        "executive",
        "form",
        "uk",
        "yearhalf",
        "firstline",
        "therapy",
        "resourcesit",
        "range",
        "value",
        "nhsprofessor",
        "chris",
        "bunce",
        "director",
        "decision",
        "state",
        "nature",
        "statement",
        "question",
        "assessment",
        "role",
        "cost",
        "need",
        "benefit",
        "body",
        "hurdle"
    ],
    "category": [
        "wires",
        "pa"
    ]
}